Research at UNC Lineberger
UNC Lineberger’s research spans the spectrum from the laboratory to the bedside to the community as our faculty work to understand the causes of cancer at the genetic and environmental levels, conduct groundbreaking laboratory research, and translate findings into innovative clinical trials.
For Researchers
- UNC Lineberger Developmental Funding Program
- Investigator Initiated Trials
- Oncology Protocol Review Committee
Center Scientific Programs
- Breast Cancer Research
- Cancer Cell Biology
- Cancer Epidemiology
- Cancer Genetics
- Cancer Prevention and Control
- Clinical Research
- Immunology
- Molecular Therapeutics
- Virology
Center Initiatives
- Cancer Information & Population Health Resource (CIPHR)
- Cancer Outcomes Research Program
- Cancer Prevention and Control Research Network (CPCRN)
- Center for Triple Negative Breast Cancer
- Carolina Cancer Screening Initiative (CCSI)
- Center for Integrative Chemical Biology and Drug Discovery (CICBDD)
- Community Outreach and Engagement
- Geriatric Oncology Program
- Global Oncology
- North Carolina – Louisiana Prostate Cancer Project (PCaP)
- UNC Health Registry
- UNC Precision Oncology Program
- UNC RNA Research Group
Patient Research Participation & Opportunities
- Patient Advocates for Research Council (PARC): PARC at UNC Lineberger provides researchers with the perspectives and experiences of patients, survivors and caregivers on issues associated with clinical studies and projects.
- Lineberger Excellence in Advocacy Program (LEAP): Cancer patients, survivors, caregivers and community members are invited to become advocates with our cancer center. Advocates work with staff and researchers to guide our programs and research studies.
- Patients And Researchers Together (PART): The PART Program is a partnership between patients, advocates, researchers and other key stakeholders to motivate patients to donate the tissue that researchers need to create new and meaningful treatments for cancer.